CritiSense

company

About

CritiSense develops technology for the real-time monitoring of patients' metabolic state and as a novel endpoint of resuscitation.

  • 1 - 10

Details

Last Funding Type
Series Unknown
Last Funding Money Raised
$1.20M
Industries
Biotechnology,Health Care
Founded date
Jan 1, 2004
Number Of Employee
1 - 10
Operating Status
Active

CritiSense was founded in 2004 on the basis of the assets of an earlier company named Vital Medical. The company's device, the Critiview, was developed by the company's co-founder and chief scientist, Professor Avraham Mayevsky, formerly head of the department of Department of Life Sciences and Dean of the Faculty of Natural Sciences at Bar Ilan University, where he established a center for tissue physiology. It provides continuous, real-time multi-parametric physiological data at the tissue and cellular level, by monitoring the mitochondrial function and the microcirculatory blood flow and oxygen saturation, by way of tissue titration therapy with an optical sensor.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$1.20M
CritiSense has raised a total of $1.20M in funding over 2 rounds. Their latest funding was raised on Jun 21, 2006 from a Series Unknown round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 21, 2006 Series Unknown $1.20M 1 Bridge Investment Fund Detail

Investors

Number of Lead Investors
Number of Investors
1
1
CritiSense is funded by 1 investors. Bridge Investment Fund are the most recent investors.
Investor Name Lead Investor Funding Round
Bridge Investment Fund Yes Series Unknown